Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Complicated intra-abdominal infections
Condition: In combination with metronidazole
Dose: Intravenous – 2.5 g (2 g/0.5 g)
Frequency: every 8 hours
Duration: 5-14 days
Note: Infused over 2 hours. Caused by susceptible gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter freundii complex, and Pseudomonas aeruginosa.
Indication: Complicated urinary tract infections
Condition: Including pyelonephritis
Dose: Intravenous – 2.5 g (2 g/0.5 g)
Frequency: every 8 hours
Duration: 7-14 days
Note: Infused over 2 hours. Caused by susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Proteus mirabilis, and Pseudomonas aeruginosa.

Child Dose

Clinical InformationAdministration Information
Indication: Complicated intra-abdominal infections
Age: 3 to less than 6 months
Dose: Intravenous – 50 mg/kg (ceftazidime 40 mg/kg and avibactam 10 mg/kg)
Frequency: every 8 hours
Duration: 5-14 days
Note: Indicated in combination with metronidazole for complicated intra-abdominal infections caused by susceptible gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter freundii complex, and Pseudomonas aeruginosa
Indication: Complicated intra-abdominal infections
Age: 6 months to less than 2 years
Dose: Intravenous – 62.5 mg/kg (ceftazidime 50 mg/kg and avibactam 12.5 mg/kg)
Frequency: every 8 hours
Duration: 5-14 days
Note: Indicated in combination with metronidazole for complicated intra-abdominal infections caused by susceptible gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter freundii complex, and Pseudomonas aeruginosa

Renal Dose

Clinical InformationAdministration Information
Age: Adult
Condition: Renal impairment with Creatinine Clearance greater than 50 mL/min
Dose: Intravenous – No dose adjustment required
Note: Standard dosing applies
Age: Adult
Condition: Renal impairment with Creatinine Clearance 31-50 mL/min
Dose: Intravenous – 1.25 grams (1 gram/0.25 grams)
Frequency: every 8 hours
Administration
  • First step: - Mix with 10mL sterile water/saline - Gently mix until clear
  • Second step: - Dilute to 50-250mL total - Solution should be clear/light yellow
Side Effect

Drug Interaction

Drug NameRisk Factors
No interactions listed
-

Disease Interaction

Disease NameRisk Factors
Serious hypersensitivity
Can cause severe allergic reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.